Spyro Mousses PhD retweeted
There is still an unmet need for patients who progress on all current breast cancer treatment options. This new next-generation SERA compound has proven to have outstanding efficacy and tolerability, which is a strong indicator that SERA2 should produce... shorturl.at/anxEJ
Spyro Mousses PhD retweeted
Oligon to Present at Biocom Global Life Science Partnering Conference.
businesswire.com/news/home/2…
Spyro Mousses PhD retweeted
Oligon™ is developing a new class of multimodal RNA therapeutics that can simultaneously silence multiple disease targets with a single RNA molecule. Our proprietary SeekR™ platform is used to digitally engineer and produce self-delivering therapeutics.
youtu.be/eeKfMemXQvM
Spyro Mousses PhD retweeted
This new laser microscope can reveal cells like never before 😱
Your Textbooks Are Wrong, This Is What Cells Actually Look Like
This new laser microscope can reveal cells like never before.
Spyro Mousses PhD retweeted
See this Instagram video by @terryfoxfoundation instagram.com/p/B-xZ7ZShEa4/…
Spyro Mousses PhD retweeted
Replying to @SystemsOncology
This research could explain why some patients with type 2 diabetes have a worse COVID-19 prognosis. It also provides a testable therapeutic intervention (ketogenic diet) that may improve the prognosis of some patients- worth testing this idea clinically. #COVIDー19
Spyro Mousses PhD retweeted
New research shows the correlation between a #KetogenicDiet and ILC2-mediated airway inflammation in mice. How does lipid metabolism play a role? Check out the link below! cell.com/immunity/fulltext/S…
See this Instagram video by @terryfoxfoundation instagram.com/p/B-xZ7ZShEa4/…
Spyro Mousses PhD retweeted
New research published in @ImmunityCP showed that restricting dietary glucose by feeding mice a #KetogenicDiet largely ablated ILC2-mediated airway inflammation by impairing fatty acid metabolism. @LIMES_Bonn https://xitter.cf/t.co/R6MdM9ynpB
New research published in @ImmunityCP showed that restricting dietary glucose by feeding mice a #KetogenicDiet largely ablated ILC2-mediated airway inflammation by impairing fatty acid metabolism. @LIMES_Bonn https://xitter.cf/t.co/R6MdM9ynpB
Systems Oncology licenses in cancer therapeutic agents from Texas A&M systemsoncology.com/news/sys…
1
Spyro Mousses PhD retweeted
Proud to announce we have received an investment from The Pritzker Organization! Check out the link below to read about our current #discovery #research and pre-clinical #development.
systemsoncology.com/news/sys…
Spyro Mousses PhD retweeted
At Innovation Day, @Novartis' Vas Narasimhan says
#clinicaltrials, AI and real-world evidence all offer promise in digital R&D #goboldly
Systems Oncology to Present Poster on Applying AI to Predict Novel Synthetic Lethal Targets at the 2019 ASCO systemsoncology.com/news/sys…
Spyro Mousses PhD retweeted
Join @SystemsImagin CEO Chris Yoo at #GTC19 as he presents on how their #AI #startup is working to understand the complex biological interactions that lead to cancer and more: nvda.ws/2VrKeiq
Spyro Mousses PhD retweeted
Just a friendly reminder our team is headed to Chicago, Illinois for #ASCO19! Come over to our poster #242 on Saturday from 8am-11am. We would love to chat and meet you all!
#AI #research #cancer #betheinnovation













